Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 2,130 Jul 31 – Oct 28, 2026
- Disclosed funding
- $147.3B 1457 disclosed amounts
- Median round
- $10M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| LT LifeMine TherapeuticsCompany profile Develops fungal genome-derived therapeutics for organ transplant rejection Develops fungal genome-derived therapeutics for organ transplant rejection | $263M | Series D+Series EUndisclosed | Biotech | United States | Investors | |
| YC Yellow CardCompany profile Provides stablecoin infrastructure enabling businesses to hold, move, and manage US dollars Provides stablecoin infrastructure enabling businesses to hold, move, and manage US dollars | $40M | StrategicUndisclosed | Fintech | United States | Investors | |
| M MossCompany profile Moss provides corporate cards, invoice management and expense workflows for European finance teams. Moss provides corporate cards, invoice management and expense workflows for European finance teams. | €35M | Series CSeries C+ | Fintech | Germany | Investors | |
| M MooveCompany profile Builds fleet ownership and depot infrastructure for autonomous vehicle operators Builds fleet ownership and depot infrastructure for autonomous vehicle operators | $250M | Series CSeries C+ | Mobility | United Arab Emirates | Investors | |
| h hiSofiCompany profile hiSofi helps businesses collect overdue payments through automated outreach and self-service debt negotiation. hiSofi helps businesses collect overdue payments through automated outreach and self-service debt negotiation. | $1M | Undisclosed | Fintech | Uruguay | Investors | |
| VB Vedanta BiosciencesCompany profile Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection | $60M | Growth | Biotech | United States | Investors | |
| ST SeeTrue TechnologiesCompany profile SeeTrue Technologies develops miniature eye-tracking hardware and embedded processing for optical instruments, smart eyewear and other devices. SeeTrue Technologies develops miniature eye-tracking hardware and embedded processing for optical instruments, smart eyewear and other devices. | €2.2M | Venture fundingUndisclosed | Hardware | Finland | Investors | |
| AS Aurelius SystemsCompany profile Develops AI-powered autonomous directed-energy systems to detect and neutralize drone threats Develops AI-powered autonomous directed-energy systems to detect and neutralize drone threats | $40M | Series A | Defense tech | United States | Investors | |
| Q QuantHealthCompany profile AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment | $45M | Series B | Biotech | Israel | Investors | |
| CL CND Life SciencesCompany profile Develops biomarker-based diagnostic tests for neurodegenerative diseases Develops biomarker-based diagnostic tests for neurodegenerative diseases | Undisclosed | Growth | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 31, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
69rounds5led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
47rounds18led - 3General Catalyst
Hyperbolic, Re:Build, Matiks
34rounds13led - 4Sequoia Capital
Hex, Nevis, Warhound
34rounds11led - 5Khosla Ventures
Arda Industries, Tolan
32rounds10led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →